Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $31,543 | 64 | 32.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $23,175 | 11 | 23.9% |
| Consulting Fee | $21,850 | 21 | 22.6% |
| Food and Beverage | $13,255 | 345 | 13.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,675 | 3 | 5.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,200 | 1 | 1.2% |
| Education | $196.43 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $90,738 | 295 | $0 (2024) |
| Boston Scientific Corporation | $2,945 | 30 | $0 (2024) |
| Abbott Laboratories | $1,364 | 29 | $0 (2024) |
| Purdue Pharma L.P. | $285.52 | 14 | $0 (2018) |
| Egalet US Inc | $203.09 | 26 | $0 (2018) |
| Stimwave Technologies Incorporated | $170.03 | 2 | $0 (2018) |
| Relievant Medsystems, Inc. | $160.21 | 1 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $135.29 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $105.68 | 8 | $0 (2018) |
| Depomed, Inc. | $105.50 | 8 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,244 | 30 | Nevro Corp. ($6,504) |
| 2023 | $8,774 | 26 | Nevro Corp. ($8,155) |
| 2022 | $38,722 | 90 | Nevro Corp. ($38,049) |
| 2021 | $27,195 | 54 | Nevro Corp. ($24,985) |
| 2020 | $4,874 | 41 | Nevro Corp. ($4,732) |
| 2019 | $5,231 | 86 | Nevro Corp. ($4,975) |
| 2018 | $2,179 | 46 | Nevro Corp. ($1,486) |
| 2017 | $2,675 | 73 | Nevro Corp. ($1,853) |
All Payment Transactions
446 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | SPINEFRONTIER, INC. | Inspan (Device) | Food and Beverage | Cash or cash equivalent | $101.83 | General |
| Category: Orthopedic | ||||||
| 12/19/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $110.80 | General |
| Category: Neuromodulation | ||||||
| 12/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/05/2024 | Nevro Corp. | Senza (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,950.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/05/2024 | Nevro Corp. | Senza (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $275.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/04/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $101.46 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/22/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Analgesic | ||||||
| 10/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $135.87 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/04/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $81.22 | General |
| Category: Neuromodulation | ||||||
| 09/30/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $134.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/29/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $134.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/28/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $134.10 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/25/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/21/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $111.27 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/20/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $46.14 | General |
| Category: Opioid Analgesic | ||||||
| 08/15/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Orthopedic | ||||||
| 07/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Opioid Analgesic | ||||||
| 07/03/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Neuromodulation | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Analgesic | ||||||
| 05/16/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: Orthopedic | ||||||
| 05/06/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $5.76 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/05/2024 | Nevro Corp. | Senza (Device) | Travel and Lodging | In-kind items and services | $31.89 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/04/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $76.03 | General |
| Category: Spinal Cord Stimulator | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,528 | 3,032 | $876,963 | $204,783 |
| 2022 | 17 | 2,532 | 8,673 | $3.5M | $762,433 |
| 2021 | 18 | 1,784 | 5,662 | $2.1M | $475,295 |
| 2020 | 20 | 2,233 | 7,930 | $3.3M | $676,906 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 100 | 150 | $180,000 | $35,462 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 384 | $115,400 | $32,263 | 28.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 188 | 298 | $89,400 | $17,592 | 19.7% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 73 | 200 | $43,800 | $16,022 | 36.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 57 | 87 | $46,194 | $15,705 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 230 | $46,920 | $14,172 | 30.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 78 | 86 | $68,800 | $13,198 | 19.2% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 232 | 435 | $83,955 | $12,257 | 14.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 71 | 196 | $33,923 | $8,812 | 26.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 23 | 29 | $34,999 | $8,666 | 24.8% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 56 | 171 | $26,505 | $6,228 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $26,500 | $5,165 | 19.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 22 | 27 | $13,862 | $4,537 | 32.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 23 | 39 | $14,792 | $4,437 | 30.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 28 | 37 | $14,063 | $4,302 | 30.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 21 | 35 | $6,808 | $1,980 | 29.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 13 | 44 | $8,100 | $1,840 | 22.7% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 12 | 12 | $6,452 | $1,724 | 26.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 105 | 519 | $16,490 | $421.09 | 2.6% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 367 | 1,433 | $1.7M | $344,775 | 20.0% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 410 | 1,884 | $565,200 | $112,261 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 354 | 1,210 | $363,000 | $109,303 | 30.1% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2022 | 419 | 1,969 | $380,017 | $61,463 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 325 | 760 | $155,040 | $46,937 | 30.3% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 97 | 247 | $54,314 | $20,257 | 37.3% |
About Dr. Joseph Dichiara, DO
Dr. Joseph Dichiara, DO is a Anesthesiology healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2011. The National Provider Identifier (NPI) number assigned to this provider is 1104118835.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Dichiara, DO has received a total of $96,894 in payments from pharmaceutical and medical device companies, with $7,244 received in 2024. These payments were reported across 446 transactions from 26 companies. The most common payment nature is "Travel and Lodging" ($31,543).
As a Medicare-enrolled provider, Dichiara has provided services to 8,077 Medicare beneficiaries, totaling 25,297 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Student in an Organized Health Care Education/Training Program, Pain Medicine
- Location Knoxville, TN
- Active Since 05/13/2011
- Last Updated 03/04/2025
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1104118835
Products in Payments
- Omnia (Device) $69,324
- Senza Spinal Cord Stimulation System (Device) $13,046
- Senza (Device) $8,368
- Superion (Device) $1,406
- VERTIFLEX SUPERION (Device) $760.45
- WaveWriter Alpha Prime 16 (Device) $497.02
- PROCLAIM (Device) $452.29
- Proclaim Family of SCS IPGs (Device) $439.65
- ETERNA (Device) $201.14
- Intracept (Device) $160.21
- Neuromodulation Dspsbls and Accs (Device) $126.26
- General - Pain Management (Device) $120.37
- ARYMO ER (Drug) $116.79
- Penta SCS Leads (Device) $111.01
- Inspan (Device) $101.83
- INTELLIS ADAPTIVESTIM (Device) $98.73
- Nucynta (Drug) $85.74
- HYSINGLA ER (Drug) $85.65
- CLINICAL TRIAL PRODUCT (Device) $81.67
- Superion Indirect Decompression System (Device) $79.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Knoxville
Benjamin Johnson, M.d, M.D
Anesthesiology — Payments: $5,398
Kyle Snyder, Md, MD
Anesthesiology — Payments: $5,178
Dr. Matthew Vance, M.d, M.D
Anesthesiology — Payments: $2,597
Dr. Gordon Collins, Md, MD
Anesthesiology — Payments: $2,520
Todd Ussery, Md, MD
Anesthesiology — Payments: $2,022
Phillip Mitchell, Md, MD
Anesthesiology — Payments: $1,591